Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
POC Lipid Testing
... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia Application, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of ... Read More
-
Positron Emission Tomography (PET)
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. PET-CT Modality, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Blood Cell Analyzer
... at a CAGR of 4.8% over the analysis period 2024-2030. Semi-Automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million by the end ... Read More
-
Exocrine Pancreatic Insufficiency
... at a CAGR of 5.8% over the analysis period 2024-2030. Exocrine Pancreatic Insufficiency Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Hematology Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the ... Read More
-
Digital Radiography
... CAGR of 5.9% over the analysis period 2024-2030. Computed Radiography (CR), one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$17.0 Billion by the end of the ... Read More
-
Vascular Imaging
... CAGR of 4.7% over the analysis period 2024-2030. MRI Technique, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.5 Billion by the end of the analysis ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Veterinary Ultrasound
... CAGR of 6.7% over the analysis period 2024-2030. 2D Ultrasound, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$231.8 Million by the end of the analysis ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Plastic Films
... CAGR of 5.8% over the analysis period 2024-2030. LLDPE Material, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis ... Read More
-
Radiation Therapy Equipment
... at a CAGR of 6.6% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.1 Billion by the ... Read More
-
Industrial X-Ray Inspection Systems
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Digital Technique, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$916.0 Million by the ... Read More
-
Cardiac POC Testing Devices
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More
-
Interventional Radiology Systems
... at a CAGR of 7.1% over the analysis period 2024-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Lateral Flow Assays
... at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Renal Denervation Technologies
... at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based Renal Denervation, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Proton Therapy
... CAGR of 13.5% over the analysis period 2024-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. ... Read More
-
RSV Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. RSV Diagnostic Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$686.6 Million by the end ... Read More
Research Assistance
